Alnylam Pharmaceuticals
ALNY
#618
Rank
S$41.05 B
Marketcap
$317.19
Share price
-10.08%
Change (1 day)
55.28%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company